Congressional opioid efforts targeting Medicare, limits on new prescriptions
A bipartisan group of senators introduced legislation Tuesday that would set a three-day initial prescribing limit on opioids for acute pain and increase recovery services and availability for addicts…Read More.
SCPC Praises Bipartisan “CARA 2.0 Act of 2018″, Stresses Importance of Recognizing Urgent Medication Needs of LTC Facility-based Seniors
National Long Term Care (LTC) Pharmacy Group Urges Congress to Follow 2016 Precedent by Exempting LTC Facilities from 3-Day Dose Provision…Read More.
Independent Pharmacies Say Drug Middlemen Are Making Them Sick
Independent pharmacy groups in several states are sick of the low insurance reimbursement rates that middlemen, known as pharmacy benefit managers, or PBMs, pay them after drugs are dispensed and they’re pushing for greater oversight of the drug middlemen…Read More.
CVS-Aetna Merger Proposal Emblematic of Growing Arms Race to Consolidate, Control Consumer Access to Health Care, Prescription Drugs
House Judiciary Subcommittee Hearing on Drug Supply Chain Should Examine Increasingly Oligopolistic Health Care System, Efforts to Monopolize Prescription Drug Marketplace…Read More.
A South Texas county drags PBMs into nationwide lawsuit over opioids
A massive lawsuit over the nation’s opioid crisis has largely ignored an influential group of companies in the prescription drug business — the financial middlemen who brokered access to the powerful pills that got so many people hooked.Read More.
To help elderly patients, CMS should prohibit PBM fees – not reform them
Over just the past few years, the nation’s three largest pharmacy benefit managers (PBMs) – CVS Caremark, Express Scripts and Optum Rx – have come to control more than 80% of prescriptions dispensed in America…Read more.
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’
Kaiser Health News
Food and Drug Administration Commissioner Scott Gottlieb said he will do everything “within my lane” to combat high drug prices and that he sees drug companies “gaming the system to try to block competition” in a multitude of ways in the marketplace…Read More.
National LTC Pharmacy Group Praises Trump White House Report Targeting PBM “Lack of Transparency”
Report Says Policies to Disrupt PBM Oligopoly “Can Reduce the Price of Drugs Paid by Consumers”…Read More.
Desperate Fig Leaf: PBM Effort to Use Non-Interference Clause to Systematize Price-Gouging
From the standpoint of the widening national debate on drug pricing issues, 2017 was a watershed year…Read more.
Senior Care Pharmacy Coalition Comments on Healthcare Choice and Competition
January 25, 2018 Via Electronic Submission: CompetitionRFI@hhs.gov John R. Graham Acting Assistant Secretary for Planning and Evaluation Department of Health and Human Services 200 Independence Avenue, S.W. Washington, D.C. 20201 Re: Response to RFI: Promoting Healthcare Choice and Competition Dear Mr. Graham: The Senior Care Pharmacy Coalition (SCPC) commends the office of the Assistant Secretary read more…